Transcenta Therapeutics

Organization

Trials

  • NCT07806331

    Phase 2, Not yet recruiting, 110 people, Sep 8, 2026

  • NCT06093425

    Phase 3, Not yet recruiting, 820 people, Oct 23, 2023

  • NCT04495296

    Phase 1/2, Active, not recruiting, 320 people, Jul 31, 2020

  • NCT04396821

    Phase 1/2, Active, not recruiting, 150 people, May 21, 2020